IscBとCas9をRNA誘導RNAエディターに変換する
Chengtao Xu1, Xiaolin Niu1, Haifeng Sun1
1Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06512, USA.
Cell
|August 19, 2025
まとめ
研究者は,Cas9の祖先であるIscBから新しいRNA編集プラットフォームを設計しました. このツールであるR-IscBは,CRISPR-Cas13に関連する細胞毒性なしに,高いRNA編集効率を提供し,遺伝子治療のより安全な代替案を示しています.
科学分野:
- 分子生物学
- 遺伝子編集技術
- 生物化学
背景:
- RNA編集はDNA編集の代替手段ですが CRISPR-Cas13のような 現在のツールには 細胞毒性があります
- より安全で効率的なRNAターゲティングツールの必要性は,治療用途において極めて重要です.
研究 の 目的:
- 高効率で細胞毒性を減らす新しいRNA編集プラットフォームを開発する.
- 既存のRNAエディタの限界を克服するIscBから派生したツールを設計する.
主な方法:
- 標的の隣接モチーフドメインを削除してR-IscBを作成し,RNA結合および編集機能を強化したIscB.
- 人間の細胞におけるR-IscBの活性が,スプライシングを変化させ,トランススプライシングを媒介し,ADAR2と融合するとA-to-I編集を可能にすることを評価した.
- 分裂ベースのmRNAノックダウンのためにHNHドメインを修正し,Cas9変種をRNAターゲティングツールに変換することを調査した.
主要な成果:
- エンジニアリングされたR-IscBは,細胞毒性を誘発することなく,Cas13に匹敵する,またはそれよりも優れた活性を示した.
- R- IscBは,スプライシングの結果を効果的に調節し,トランススプライシングを通じてmRNAレベルでの変異を修正しました.
- このプラットフォームは,効率的なmRNA A-to-I編集と分裂ベースのノックダウンを容易にし,いくつかのCas9変種はRNAターゲティングに再利用されました.
結論:
- IscBから派生したR-IscBプラットフォームは,RNA編集と操作のための強力で安全な代替手段を提供します.
- この工学的なシステムは RNAターゲティング技術の範囲を拡大し 新しい治療の可能性を提供します
- この研究は,次世代の遺伝子編集ツールの開発における祖先のタンパク質の可能性を強調しています.
さらに関連する動画
11:35Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
12.7K
07:46CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
6.0K
関連する概念動画
CRISPR/Cas9 Genome Editing
213
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
213
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
RNA Editing
9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K
Homologous Recombination
51.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
51.7K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
